VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $78,164 | -82.5% | 19,018 | -82.0% | 0.00% | -100.0% |
| Q4 2023 | $446,282 | -60.0% | 105,754 | -59.0% | 0.00% | -66.7% |
| Q3 2023 | $1,114,331 | -43.9% | 257,947 | -14.4% | 0.00% | -57.1% |
| Q2 2023 | $1,985,112 | -7.3% | 301,231 | -4.5% | 0.01% | -78.1% |
| Q1 2023 | $2,141,356 | +97.1% | 315,369 | +114.5% | 0.03% | +60.0% |
| Q4 2022 | $1,086,626 | -48.6% | 147,040 | -24.3% | 0.02% | -65.5% |
| Q2 2022 | $2,116,000 | +192.3% | 194,164 | +203.1% | 0.06% | +205.3% |
| Q1 2022 | $724,000 | -57.5% | 64,050 | -41.0% | 0.02% | -64.2% |
| Q4 2021 | $1,702,000 | – | 108,491 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |